Posted on 03/11/2009 in Medical Company Financials Cynosure has posted its financial results for the third quarter of this year.
Revenues for the three months ended September 30th 2009 were $17.9 million (10.9 million pounds), compared with $38.2 million for the same period of 2008 and $20.8 million during the second quarter of this year.
The decrease is something the firm attributes to the economic downturn and the effects of a restrictive credit environment in various markets.
President and chief executive officer of Cynosure Michael Davin commented: "The positive news we take from the current environment is that, as credit begins to ease, we believe the underlying demand is there to support the industry's return to growth."
Some of the firm's recent activities include the introduction of the product Smartlipo Triplex - the world's first laser lipolysis workstation to feature three wavelengths that combine to deliver high-powered fat absorption and tissue tightening through coagulation.
Other news stories from 03/11/2009
Read more in the Zenopa News Archive
How this news is generated
|
